极低出生体重儿的重组组织型纤溶酶原激活剂治疗
Recombinant tissue-type plasminogen activator treatment in an extremely low birth weight infant.
作者信息
Kurimoto Tomonori, Shimoji Yoshikazu, Shimabukuro Atsuya, Ohshiro Tatsuo
机构信息
Okinawa Prefectural Nanbu Medical Center and Children's Medical Center Okinawa Japan.
出版信息
Clin Case Rep. 2021 May 15;9(5):e04236. doi: 10.1002/ccr3.4236. eCollection 2021 May.
Abstract
Tissue plasminogen activator can effectively treat clinical thrombosis in premature infants 11 hours after birth.
摘要
组织型纤溶酶原激活剂可在出生后11小时有效治疗早产儿的临床血栓形成。
Zotero 插件